Category

Daily Briefs

Daily Brief Industrials: Teco Electric & Machinery, Verisure Holding, Delhi International Airport Limited, Hosokawa Micron, Monadelphous, Norcros PLC, Stanley Black & Decker, Aeorema Communications, Willdan Group, Curtiss Wright and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Yuanta/P-Shares Taiwan Div+ ETF Rebalance Preview: 3 Changes; US$4bn Trade
  • STOXX Europe600 Dec25 Forecast: VSURE, VEND & MTLN Leading Top Additions
  • Lucror Analytics – Morning Views Asia
  • Primer: Hosokawa Micron (6277 JP) – Nov 2025
  • Primer: Monadelphous (MND AU) – Nov 2025
  • Norcros – Hiding in plain sight
  • Stanley Black & Decker’s Margin Strategy: Can China Diversification Up Its Game?
  • Hybridan Small Cap Feast: 18 November 2025
  • Willdan Group Just Acquired Compass Municipal Advisors—Is The Deal A Potential Game Changer?
  • Curtiss-Wright: Powering Ahead With Game-Changing AP1000 Nuclear Expansion But Is It Enough?


Yuanta/P-Shares Taiwan Div+ ETF Rebalance Preview: 3 Changes; US$4bn Trade

By Brian Freitas

  • With the review period now complete, there could be 3 constituent changes for the Yuanta/​P-Shares Taiwan Dividend Plus ETF in December.
  • Constituent changes along with capping changes will lead to a one-way turnover of 12.7% and in a round-trip trade of TWD 125bn (US$4bn).
  • There are multiple stocks that have same-way or opposite flow from trackers of other Taiwan indices and present some interesting trading opportunities.

STOXX Europe600 Dec25 Forecast: VSURE, VEND & MTLN Leading Top Additions

By Dimitris Ioannidis


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Delhi Int’l Airport
  • UST yields fell yesterday, led by the long end, on the back of a solid 2-year note auction and surprisingly dovish comments from San Francisco Fed President Mary Daly. The yield on the 2Y UST declined 1 bp to 3.50%, while that on the 10Y UST was down 4 bps at 4.03%.
  • Equities rose for a second day, as tech stocks recovered slightly from the prior week’s sell-off. The S&P 500 advanced 1.5% to 6,705, and the Nasdaq jumped 2.7% to 22,872.

Primer: Hosokawa Micron (6277 JP) – Nov 2025

By αSK

  • Hosokawa Micron is a global leader in the niche market of powder and particle processing equipment, commanding an estimated 30% global market share. Its technology is critical for a wide array of industries, including pharmaceuticals, electronics (notably battery materials), chemicals, and food products.
  • The company is strategically focused on enhancing profitability through its ‘Unique & Dominant’ medium-term plan, aiming to develop distinctive products that solve customer problems and strengthen engineering capabilities to secure large-scale projects. This strategy is geared towards achieving long-term targets of JPY 150 billion in sales and an operating margin of 12%.
  • Financial performance has shown resilience, with record operating profit in FY2024 despite a challenging global environment. While recent sales have seen a slight decline, the company has effectively managed costs and improved gross margins, maintaining a strong balance sheet with a high capital adequacy ratio.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Monadelphous (MND AU) – Nov 2025

By αSK

  • Monadelphous is a leading Australian engineering group specializing in construction and maintenance services for the resources, energy, and infrastructure sectors. Its dual-division structure allows it to capture opportunities across the full asset lifecycle.
  • The company is experiencing a period of strong growth, driven by significant contract wins in its core markets, particularly in iron ore and energy. A robust project pipeline and strategic acquisitions are expected to support continued revenue momentum.
  • While exposed to the cyclical nature of the resources sector and persistent skilled labor shortages, Monadelphous‘ strong balance sheet, long-term client relationships with blue-chip companies, and diversification into renewable energy and critical minerals position it to navigate market uncertainties.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Norcros – Hiding in plain sight

By Equity Development

  • Margin progression, cash generation and dividend growth – as well as a material, post period end acquisition – were all notable features of H1 26.
  • A sharpened and connected business portfolio with leading market positions, clear strategic growth drivers and demonstrable results are together delivering above sector performance against a generally subdued economic backdrop.
  • The foundations are in place to continue to capture market share in a more favourable cyclical environment, though this is not currently factored in.

Stanley Black & Decker’s Margin Strategy: Can China Diversification Up Its Game?

By Baptista Research

  • Stanley Black & Decker’s third quarter 2025 results reflect a mixed performance with some positives and notable challenges.
  • The company’s revenue for the quarter stood at $3.8 billion, marking a flat performance compared to the previous year, with an organic decline of 1%.
  • This outcome was primarily driven by a 6% decline in volume, which offset a 5% increase in pricing.

Hybridan Small Cap Feast: 18 November 2025

By Hybridan

  • The strategic communications Company provided a trading update for the 18-month period ended 31 December 2025.
  • For comparative purposes, unaudited figures for the 18-month period ended 31 December 2024 were used.
  • Revenue is expected to be no less than £29m (18 months 2024: £27.5m), with underlying profit before tax (excluding one-off restructuring costs) of no less than £700k (18 months 2024: £318k).

Willdan Group Just Acquired Compass Municipal Advisors—Is The Deal A Potential Game Changer?

By Baptista Research

  • In a strategic move to strengthen its foothold in financial and municipal advisory services, Willdan Group announced the acquisition of Compass Municipal Advisors through its subsidiary, Willdan Financial Services.
  • The transaction is expected to close by January 1, 2026, and comes amid a record-breaking Q3 performance where Willdan posted 26% net revenue growth and 20% organic growth, bolstered by booming demand in electrification and data center infrastructure.
  • With margins expanding and EBITDA reaching a quarterly high of $23.1 million, the company has raised its fullyear 2025 financial targets.

Curtiss-Wright: Powering Ahead With Game-Changing AP1000 Nuclear Expansion But Is It Enough?

By Baptista Research

  • Curtiss-Wright Corporation reported its third-quarter 2025 financial results, revealing both strengths and challenges that investors should consider.
  • The company demonstrated solid operational performance across its three segments, contributing to a favorable financial outlook and robust market positioning.
  • In terms of financial highlights, Curtiss-Wright achieved a significant increase in revenue, which was $869 million, marking a 9% year-over-year growth, including 6% organic growth.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: SK Biopharmaceuticals , GE HealthCare Technologies , Abbott Laboratories, Island Pharmaceuticals , QIAGEN NV, Royalty Pharma , Tempus AI, Zimmer Biomet Holdings, BioLine RX , Fujian Lemo IoT Technology and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • SK Biopharmaceuticals (326030 KS): Swelling Xcopri Sales in US Drives Record High 3Q Earnings
  • GE HealthCare’s $2.3 Billion Acquisition Of Intelerad: Game-Changer Or Growing Pains?
  • Abbott Labs’ Exact Sciences Acquisition: What Could Go Right In This $21 Billion Cancer Play?
  • Island Pharmaceuticals Ltd – De-risking the commercial path
  • QIAGEN: Benefitting From Structural Demand Tailwinds in Molecular Diagnostics
  • Royalty Pharma: Can Imdelltra’s $700 Million Launch Ignite a Multi-Billion Dollar Cancer Breakthrough?
  • Tempus Labs: Inside the $100M Data Boom—How Licensing Deals Are Reshaping Its Future!
  • Zimmer Biomet: Can Its Surge in Knees and Hips Spark a Major Market Comeback?
  • BLRX: Stem Cell Mobilization Presentation at ASH
  • Pre-IPO Lemo Services Co., Ltd (PHIP Updates) – Some Points Worth the Attention


SK Biopharmaceuticals (326030 KS): Swelling Xcopri Sales in US Drives Record High 3Q Earnings

By Tina Banerjee

  • SK Biopharmaceuticals (326030 KS) reported record high quarterly earnings in 3Q25 on surging U.S. sales of Xcopri, which surpassed quarterly revenue of $100M for the second time.
  • Revenue from Xcopri in the U.S. increased 52% YoY (accelerated from 47% YoY reported in 2Q25) and 12% QoQ to record high of KRW172B, on enhanced marketing efforts.
  • For full-year 2025, SKBP guided for Xcopri U.S. revenue of $420–450M (~KRW570–610B), up 31–40% YoY. During first nine months of 2025, Xcopri U.S. revenue reached $325M (KRW460M).

GE HealthCare’s $2.3 Billion Acquisition Of Intelerad: Game-Changer Or Growing Pains?

By Baptista Research

  • GE HealthCare Technologies is moving deeper into the software space with its planned $2.3 billion acquisition of Intelerad, a Montreal-based provider of enterprise imaging software.
  • As the healthcare landscape shifts toward outpatient and ambulatory settings, this acquisition signals GE HealthCare’s strategic push to diversify beyond its traditional inpatient stronghold.
  • Intelerad’s platform includes radiology PACS, cloud-based image sharing, and workflow solutions, which could dovetail with GE’s diagnostic imaging portfolio.

Abbott Labs’ Exact Sciences Acquisition: What Could Go Right In This $21 Billion Cancer Play?

By Baptista Research

  • Abbott Laboratories has made headlines once again, this time for a bold push into cancer diagnostics through its proposed $21 billion acquisition of Exact Sciences.
  • The deal, which values Exact at $105 per share in cash and represents a 51% premium over its last closing price, is poised to be the largest healthcare M&A deal in two years and the biggest ever in the diagnostics space.
  • Slated to close in Q2 2026, the transaction marks Abbott’s strategic expansion beyond glucose monitoring and cardiovascular devices into oncology testing—a market the company had eyed for years.

Island Pharmaceuticals Ltd – De-risking the commercial path

By RaaS Research Group (RaaS)

  • Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
  • The company has made two recent announcements that improve its chances of selling Galidesivir for Marburg to the US government, ahead of potential FDA clearance of the drug.
  • On 20 November 2025 it announced the appointment of leading Washington D.C. based federal government affairs and lobbying firm, Todd Strategy Group (TSG), to support US government engagement.

QIAGEN: Benefitting From Structural Demand Tailwinds in Molecular Diagnostics

By Baptista Research

  • QIAGEN’s third-quarter 2025 earnings call revealed both strengths and challenges that define the company’s current performance and future outlook.
  • The company’s focus on high-growth areas of molecular research and testing has led to a steady performance amidst a challenging macroeconomic environment, yet various strategic initiatives and external pressures influence its trajectory.
  • On the positive side, QIAGEN continues to demonstrate robust operational execution.

Royalty Pharma: Can Imdelltra’s $700 Million Launch Ignite a Multi-Billion Dollar Cancer Breakthrough?

By Baptista Research

  • Royalty Pharma delivered a solid third quarter, showcasing an 11% growth in both their portfolio receipts and royalty receipts.
  • This growth is largely driven by their diversified portfolio, which remains a key strength of the company.
  • Their stable returns on invested capital at 15.7% and returns on invested equity at 22.9% demonstrate efficient capital management.

Tempus Labs: Inside the $100M Data Boom—How Licensing Deals Are Reshaping Its Future!

By Baptista Research

  • Tempus AI’s third-quarter financial performance in 2025 presented a mixed picture with several encouraging elements coupled with areas of potential concern or uncertainty.
  • The company demonstrated robust growth in its genomic and data licensing businesses, achieving a significant milestone of positive adjusted EBITDA for the first time in its history.
  • In particular, Tempus AI reported a 33% increase in overall genomic volume, with oncology and hereditary tests growing at 27% and 37%, respectively.

Zimmer Biomet: Can Its Surge in Knees and Hips Spark a Major Market Comeback?

By Baptista Research

  • The third quarter of 2025 saw Zimmer Biomet deliver a mixed performance, demonstrating both strengths and areas of concern.
  • The company achieved a sales growth of 5% on an organic constant currency basis, highlighted by a significant improvement in its U.S. business, which increased by 5.6%.
  • Key product lines such as the Persona OsseoTi Cementless Total Knee and the Oxford Partial Cementless Knee showed strong adoption, contributing to an overarching success in the knee segment, which grew 5.3%.

BLRX: Stem Cell Mobilization Presentation at ASH

By Zacks Small Cap Research

  • BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting indications in stem cell mobilization (SCM) & in the treatment of advanced pancreatic cancer.
  • The candidate is approved in the US for SCM and is undergoing studies for use in gene therapy and in pancreatic cancer.
  • Gloria Biosciences has delayed the start of its motixafortide studies in Asia and the path forward is unclear.

Pre-IPO Lemo Services Co., Ltd (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Lemo can replicate on a large scale through offline outlets to reduce operating costs.But this model is characterized by heavy assets, with a single profit model of limited risk resistance.
  • Insufficient rigid demand is a major challenge for the industry.The declining revenue growth reflects the ineffective business expansion of Lemo, and the Company may have already encountered a growth ceiling. 
  • Valuation of Lemo would be lower than peers due to the concerns of business expansion and slowing revenue. For example, 12-15x P/E may provide more safety margin for investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Alibaba, United Arrows, Mars Group Holdings, Life Time Group Holdings, AO World PLC, Tesla , Yum China Holdings , LOTTE Corporation, Marriott International, Bombay Burmah Trading and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Alibaba (BABA, 9988 HK): F2Q26, Up by 18% Excluding Disposals
  • United Arrows on a Roll Again with Korean Brands
  • Primer: Mars Group Holdings (6419 JP) – Nov 2025
  • Life Time Inc. Unleashes a High-End Expansion—Is Its Affluent Club Strategy a Game Changer?
  • AO World – 5* strategy delivers another profit upgrade
  • Tesla Stock Collapse: The AI Trade That Backfired!
  • Yum China Drops Game-Changing Formats—How Mini Stores & KCOFFEE Are Rewriting the Playbook!
  • Lotte Corp: Worsening Balance Sheet Offset by Its High Treasury Shares Level
  • Marriott’s Sonder Disaster: Evictions, Bankruptcy & A Billion-Dollar Blame Game!
  • Primer: Bombay Burmah Trading (BBTC IN) – Nov 2025


Alibaba (BABA, 9988 HK): F2Q26, Up by 18% Excluding Disposals

By Ming Lu

  • In F2Q26, pro forma revenue increased by 18% YoY excluding two disposals.
  • It was successful that the company rebranded its food delivery business.
  • However, the rebranding brought significant sales and marketing expenses in F2Q26.

United Arrows on a Roll Again with Korean Brands

By Michael Causton

  • United Arrows is beginning to flex its market power by launching more new brands rather than just iterations of its eponymous name
  • A key focus is a move to exploit the massive demand for Korean brands in Japan with Korean licenses for Nice Weather and Osoi.
  • More licenses are expected in the near future as the select shop retailer looks to take more share of the premium market.

Primer: Mars Group Holdings (6419 JP) – Nov 2025

By αSK

  • Mars Group Holdings exhibits a compelling value and dividend profile, underpinned by a robust history of financial growth and a strong net cash position, making it attractive for income-oriented investors.
  • The company’s primary exposure to the Japanese pachinko industry presents a significant headwind, as the market is in a long-term structural decline due to demographic shifts, regulatory pressures, and competition from other entertainment forms.
  • A recent downturn in quarterly performance (FY1Q26) following years of strong growth introduces uncertainty, making near-term earnings and regulatory developments critical catalysts to monitor.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Life Time Inc. Unleashes a High-End Expansion—Is Its Affluent Club Strategy a Game Changer?

By Baptista Research

  • Life Time Group Holdings Inc. reported its third-quarter 2025 financial results, showcasing significant growth across several metrics, indicative of effective strategic execution and market positioning.
  • Total revenue rose by 12.9% to $783 million, supported by an increase in average monthly dues per member and robust comparable center revenue, which grew 10.6% over the prior year.
  • Moreover, membership remained stable with 841,000 center memberships and total memberships reaching 891,000, in line with the company’s expectations.

AO World – 5* strategy delivers another profit upgrade

By Equity Development

  • AO’s impressive H126 results show strategic, customer-focussed progress.
  • 14% revenue growth reflects market share gains, and Adj. PBT rose 10% despite payroll cost headwinds.
  • AO’s differentiated 5* membership programme and sustained 5* customer service underpin its success, whilst improved profit trends in mobile and musicMagpie contribute to the positive outlook.

Tesla Stock Collapse: The AI Trade That Backfired!

By Baptista Research

  • Tesla’s latest earnings and strategic updates present a revealing picture of a company navigating an increasingly complex path.
  • The electric vehicle and clean energy giant is caught between near-term financial pressure and long-term ambitions rooted in AI, autonomy, and robotics.
  • While recent quarterly results missed Wall Street’s expectations—adjusted earnings came in at 40 cents per share and revenue dropped 12% year-over-year to $22.5 billion—investor focus has shifted beyond EV sales.

Yum China Drops Game-Changing Formats—How Mini Stores & KCOFFEE Are Rewriting the Playbook!

By Baptista Research

  • Yum China Holdings Inc., a licensee of Yum!
  • Brands in China, presented mixed results in the third quarter of 2025.
  • On a positive note, Yum China reported a record $400 million in adjusted operating profit, marking an 8% increase year-over-year.

Lotte Corp: Worsening Balance Sheet Offset by Its High Treasury Shares Level

By Douglas Kim

  • Despite the higher probability of the cancellation of treasury shares by Lotte Corp, we believe that its worsening balance sheet is a greater concern. 
  • There does not appear to be a rapid business turnaround of its major affiliates including Lotte Chemical. As a result, we are concerned about further credit downgrades in 2026/2027.
  • Our base case NAV valuation of Lotte Corp is market cap of 2.2 trillion won or target price of 20,918 won per share, which is 29% lower than current price.

Marriott’s Sonder Disaster: Evictions, Bankruptcy & A Billion-Dollar Blame Game!

By Baptista Research

  • Marriott International’s third-quarter 2025 results demonstrate a mixed performance with several key indicators reflecting the broader intricacies of the global hospitality market.
  • On the positive side, Marriott reported financial outcomes that exceeded previous expectations, driven largely by a solid development pipeline and significant portfolio growth.
  • The company expanded its room repertoire by 4.7% year-over-year, reaching over 1.75 million rooms across more than 9,700 properties worldwide.

Primer: Bombay Burmah Trading (BBTC IN) – Nov 2025

By αSK

  • Bombay Burmah Trading Corporation (BBTC) is a diversified holding company of the Wadia Group, with its intrinsic value primarily derived from its ~50.5% stake in the fast-moving consumer goods (FMCG) major, Britannia Industries.
  • The company trades at a significant and persistent discount to the market value of its underlying assets, offering potential for substantial value unlocking. However, this discount is perpetuated by the underperformance of its standalone businesses and concerns over capital allocation.
  • BBTC’s standalone operations, mainly in tea plantations and auto-electric components, face industry-specific headwinds and have historically yielded modest returns, weighing on the consolidated financial performance and investor sentiment.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Qube Holdings, Monash IVF, Bluescope Steel, Technology One and more

By | Australia, Daily Briefs

In today’s briefing:

  • Qube Holdings (QUB AU): Macquarie’s NBIO at A$5.20
  • Monash IVF (MVF AU) Rejects Soul Patts/Genesis’ Offer
  • Bluescope (BSL AU) Vs. Short Sims (SGM AU): Pair Trade Back in Play
  • Technology One Ltd – Outlook Intact Post Tech1’s FY25 Punishment


Qube Holdings (QUB AU): Macquarie’s NBIO at A$5.20

By Arun George

  • Qube Holdings (QUB AU) has received a non-binding proposal from Macquarie Asset Management (MAM) at A$5.20 per share, a 27.8% premium to the undisturbed price.
  • The Board has granted exclusive due diligence until 1 February 2026 (or 15 February under certain circumstances). A scheme offer would be conditional on FIRB and ACCC approval. 
  • While the offer represents an all-time high, the scarcity value of high-quality infrastructure assets could spur a competing bid from others, such as Brookfield, which holds pre-emptive rights at Patrick.

Monash IVF (MVF AU) Rejects Soul Patts/Genesis’ Offer

By David Blennerhassett

  • Monash IVF (MVF AU), a fertility provider, has announced, and summarily rejected, a A$0.80/share non-binding indicative Offer from Washington H. Soul Pattinson and Co. Ltd (SOL AU) & Genesis Capital.
  • The indicative terms are a ~31% premium to last close. And ~7.7x FY25 EV/EBITDA. Chairman Richard Davis declared terms “opportunistic in timing and materially undervalues the company“. 
  • Genesis/Soul Patts collectively hold 19.6% in MVF.  MVF’s share price has cratered this year after a woman was mistakenly implanted with the wrong embryo. The CEO subsequently stepped down. 

Bluescope (BSL AU) Vs. Short Sims (SGM AU): Pair Trade Back in Play

By Gaudenz Schneider

  • Context: The Bluescope Steel (BSL AU) vs. Sims Metal Management (SGM AU) price-ratio has deviated two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Bluescope (BSL AU) and short Sims (SGM AU) targets a 6% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Technology One Ltd – Outlook Intact Post Tech1’s FY25 Punishment

By FNArena

  • Shares in TechnologyOne reacted negatively on the release of a record FY25 performance, as not all metrics met elevated expectations and as the global technology sector is de-rated.
  • -TechnologyOne delivers record FY25 metrics -Profit exceeds guidance, strong UK growth -Market concerns on softer than expected ARR and NRR -Global de-rating for the sector equally impacts on updated valuations/price targets

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: The Game Has Changed Since the Era of Cross-Shareholdings and more

By | Daily Briefs, ESG

In today’s briefing:

  • The Game Has Changed Since the Era of Cross-Shareholdings


The Game Has Changed Since the Era of Cross-Shareholdings

By Aki Matsumoto

  • Share buybacks peak every year in June when AGMs are held, after which the “Quiet Period” begins. Toward the fiscal year-end, buybacks are expected as a means to resolve cross-shareholdings.
  • Given that the capital profitability of all TSE-listed companies hasn’t shown improvement, investors must continue to call for reducing excess cash reserves through dissolution of cross-shareholdings and the share buybacks.
  • Shareholders entrust management with the responsibility to maximize shareholder interest, which includes shareholder returns and corporate value growth. It’s natural for shareholders to demand that management fulfill this fiduciary duty.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Did The Elon & Jensen Clown Show Just Crater The AI Narrative? and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Did The Elon & Jensen Clown Show Just Crater The AI Narrative?
  • Ohayo Japan | Gemini 3; Nasdaq 2.7
  • Why America’s Cattle Ranchers Keep Getting Squeezed
  • Singapore Market Roundup (24-Nov-2025): Morningstar keeps US$7.10 target on Hongkong Land.
  • US Banks – New HFD Shows Loans Accelerating Further at 5.22% YoY, Highest Pace in 2 Years
  • The Shine’s Come Off The Neocloud Trade, But That Could Be An Opportunity
  • India’s Labor Code Reform: What Global Investors Should Know?
  • Exencial Industry Tidings 24/11/2025


Did The Elon & Jensen Clown Show Just Crater The AI Narrative?

By William Keating

  • Maybe it’s 10, 20 years something like that. For me that’s long term. Um my prediction is that work will be optional.
  • The evidence speaks for itself uh but but but AI and humanoid robots will actually eliminate poverty and Tesla won’t be the only one that makes them.
  • There will still be constraints on power like electricity. The fundamental physics elements will still be constraints. Um but um I think at some point uh currency becomes irrelevant.

Ohayo Japan | Gemini 3; Nasdaq 2.7

By Mark Chadwick

  • Strong US stock gains since Friday should drive bargain hunting in oversold AI-related Japanese names following their recent slide.
  • Prospects for a near-term US rate cut may limit yen weakness, supported by Japanese officials’ strong verbal intervention on Friday.
  • The US market closure on Thursday will reduce overall trading volume, potentially leading to increased volatility for individual stocks in Japan.

Why America’s Cattle Ranchers Keep Getting Squeezed

By Odd Lots

  • Rising beef prices in the US are a topic of concern, with President Trump urging lower prices
  • Bill Bullard, CEO of R-CALF USA, discusses the relationship between beef prices and cattle prices and the need for competitive market forces in the cattle industry

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Singapore Market Roundup (24-Nov-2025): Morningstar keeps US$7.10 target on Hongkong Land.

By Singapore Market Roundup

  • Morningstar maintains US$7.10 target on undervalued Hongkong Land. Singapore tourism benefits from China trip cancellations, says DBS.
  • UBS values Sembcorp Industries at $7.65 due to a value unlock.
  • Analysts maintain ‘buy’ ratings on Centurion Corp after 3QFY2025 update. BRC Asia’s 2HFY2025 earnings fall 5% y-o-y to $52.2 million.

US Banks – New HFD Shows Loans Accelerating Further at 5.22% YoY, Highest Pace in 2 Years

By Daniel Tabbush

  • New high frequency data from the Fed in its weekly H8 series for US banks, shows loan growth at 5.22% YoY in week 12 November
  • There has not been a higher rate in a long time, since mid FY23 where the data is distorted from a low base effect in FY22
  • Steepening slope of weekly loan growth together with no real rise in loan loss allowance, gives a strong view of US credit metrics, demand

The Shine’s Come Off The Neocloud Trade, But That Could Be An Opportunity

By Finimize Research

  • Bubble fears and a broad market selloff have dragged down the stocks of neocloud companies and bitcoin miners pivoting to AI.
  • These firms have their challenges: supply chain issues, growing debt loads, uncertainty about Nvidia chip lifespans, and the rapid drop in bitcoin prices.
  • Power’s still a prized asset – so, if investor sentiment improves, miners with strong energy assets and Nebius, with its loaded contract pipeline, could be the first to benef

India’s Labor Code Reform: What Global Investors Should Know?

By Nimish Maheshwari

  • The four new Labour Codes on Wages, Industrial Relations, Social Security, and OSHWC, replace 29 old laws, creating a unified, simplified, and future-ready framework for India’s labour sector.
  • The Codes expand social security to gig/platform workers, mandate appointment letters, and introduce flexibility measures, directly addressing India’s formalization and productivity deficit.
  • Structural shifts toward formal employment, financial inclusion, and manufacturing flexibility will boost corporate investment, productivity, and inclusive growth, justifying a re-rating of India’s formal sector.

Exencial Industry Tidings 24/11/2025

By Viral Kishorchandra Shah

  • Govt to increase sugar MSP by 23% to Rs.38 per kg
  • Shrimp exports rise by 18% to USD 2.4 bln during Apr-Aug 2025
  • Textiles industry’s sales grow by 4.9% in September 2025 quarter

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: UltraGreen.AI, Rubber Future SGX TSR20, iEdge Singapore Next 50 Index, Banyan Tree Holdings, Suntec REIT and more

By | Daily Briefs, Singapore

In today’s briefing:

  • UltraGreen.ai IPO: High Growth and High Margins, Market Leader
  • India’s Synthetic Rubber Sector Steadies Amid Import Decline
  • Comparing the Singapore Next 50 to Its Regional Peers: An Asia Portfolio Context
  • Tourism and Real Estate Stocks Dominate Filed Transactions Last Week
  • REIT Watch – Positive momentum for Office S-REITs as vacancy rates ease and rents climb


UltraGreen.ai IPO: High Growth and High Margins, Market Leader

By Hong Jie Seow

  • UltraGreen.AI (2594794D SP) is looking to raise US$400m in its upcoming Singapore IPO.
  • UltraGreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
  • We have looked at the company’s past performance in our previous note. In this note, we talk about valuations.

India’s Synthetic Rubber Sector Steadies Amid Import Decline

By Vinod Nedumudy

Highlights

• Consumption outpaces domestic production growth

• Imports decline despite steady industrial demand

• Fresh probe into halobutyl rubber dumping

The first four months of the financial year illustrated an industry striving for balance — one still navigating between domestic self-sufficiency ambitions and dependence on imports for certain specialized grades. Demand from tire makers, which account for nearly two-thirds of synthetic rubber use in India, remained stable amid mixed trends in automotive production and exports. 


Comparing the Singapore Next 50 to Its Regional Peers: An Asia Portfolio Context

By Jay Cameron

  • This insight compares the iEdge Singapore Next 50 Index with regional mid-cap indices, focusing on methodology, sector composition, and historical performance. 
  • Combining flagship and next-tier indices can broaden sector exposure and balance within an Asia-focused equity portfolio. 
  • A volatility-driven allocation strategy is presented, showing that dynamic mid-cap exposure can help moderate drawdowns and enhance returns during market cycles.

Tourism and Real Estate Stocks Dominate Filed Transactions Last Week

By Geoff Howie

  • Institutions were net sellers of Singapore stocks from Nov 14 to Nov 20, with a net outflow of S$131 million.
  • United Overseas Bank led share buybacks, acquiring 997,700 shares at an average price of S$34.01, totaling S$58.2 million.
  • Wing Tai Holdings’ Cheng Wai Keung increased his interest to 62.24%, while Banyan Tree Holdings’ Goodview Properties raised its stake to 6.06%.

REIT Watch – Positive momentum for Office S-REITs as vacancy rates ease and rents climb

By Geoff Howie

  • In 3Q25, Singapore office REITs like CICT, MPACT, and Suntec REIT reported strong occupancy and positive rental reversions.
  • CICT’s office portfolio occupancy rose to 96.2%, with a 1.9% rent increase, and full ownership of CapitaSpring.
  • Keppel REIT achieved a 12.0% rental reversion, maintaining 96.3% occupancy, with a WALE of 4.7 years.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: LOTTE Corporation, Gabia Inc, Smec Co Ltd, Samsung SDI and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Ruling Party Unveils Key Details of 3rd Commercial Act Amendment: Mandatory Treasury-Share Disposal
  • A Tender Offer of 10% Stake in Gabia by Align Partners Asset Management
  • SNT Group – Formalizes a Hostile Takeover of SMEC
  • Primer: Smec Co Ltd (099440 KS) – Nov 2025
  • Samsung SDI (006400): When Is the Buying Opportunity?


Ruling Party Unveils Key Details of 3rd Commercial Act Amendment: Mandatory Treasury-Share Disposal

By Sanghyun Park

  • The proposed bill fully closes the treasury-share loopholes, bans all exchangeable/pledge uses, blocks M&A allocations, and imposes strict cancellation deadlines—1 year for new buys, 6 months for existing.
  • The amendment tightens disposal rules: no cancellation means pro-rata sales to existing shareholders only, shutting down selective deals and closing the wide-open disposal gap under current law.
  • The proposal is far tougher than expected, likely to become the final version, and should drive a near-term mandatory-cancel narrative and notable price action in governance-sensitive holding-co names.

A Tender Offer of 10% Stake in Gabia by Align Partners Asset Management

By Douglas Kim

  • After the market close on 24 November, it was announced that Align Partners is conducting a partial tender offer of a 10% stake in Gabia Inc (079940 KS). 
  • Tender offer price is 33,000 won (20% higher than current price). Tender offer amount is 44.7 billion won. 
  • If Align Partners successfully completes this tender offer, its stake would rise to 19.03%. Plus, the combined stakes of Align Partners and Miri Capital would be 42.99%. 

SNT Group – Formalizes a Hostile Takeover of SMEC

By Douglas Kim

  • On 24 November, the SNT Group formalized its hostile takeover of Smec. S&T Holdings  disclosed that it acquired an additional 5.46% stake in SMEC, raising its stake to 13.65%.
  • S&T Holdings and SNT Group Chairman Choi combined own a 20.2% stake in SMEC. In comparison, the SMEC CEO Choi Young-seop owns a 9.75% stake in SMEC.
  • In our view, this is likely to lead to a potential fight for the control of SMEC’s management rights, pushing up the share price of SMEC even further.

Primer: Smec Co Ltd (099440 KS) – Nov 2025

By αSK

  • Smec Co Ltd is a South Korean company with dual exposure to the cyclical machine tool industry and the evolving telecommunications sector. Its machinery division, rooted in Samsung Heavy Industries, produces CNC lathes, machining centers, and robotic automation solutions. The ICT division provides various gateway solutions.
  • The company is strategically positioned to benefit from the growth in factory automation and the transition to electric vehicles (EVs), which require advanced manufacturing equipment. Recent corporate actions, including a significant stake acquisition by SNT Holdings with the stated purpose of influencing management, could signal a strategic shift and a more aggressive approach to enhancing corporate value.
  • Despite a strong growth track record in revenue and net income over the past several years, the company faces intense competition from larger domestic players and is susceptible to the capital expenditure cycles of its key end-markets. The lack of a consistent dividend payment may be a deterrent for income-focused investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Samsung SDI (006400): When Is the Buying Opportunity?

By Henry Soediarko

  • Recent quarters operating numbers for Samsung SDI (006400 KS) is quite poor and have caused the share price to decrease accordingly. 
  • The share price has rallied on the back of the news on Tesla’s new business to order ESS from Samsung SDI. 
  • At what level shall investors start to accumulate Samsung SDI. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: UltraGreen.ai IPO: High Growth and High Margins and more

By | Daily Briefs, ECM

In today’s briefing:

  • UltraGreen.ai IPO: High Growth and High Margins, Market Leader
  • Klook Travel Technology (KLK): Peeking at the IPO Prospectus of a Hong Kong Based Travel Platform
  • Chagee Holdings (CHA) Six-Month Summary: Stark Warning on Volatility, China-Based IPO Risk
  • Hornbeck Offshore Services, Inc. (HOS): Peeking at the IPO Prospectus of Marine Services Company
  • NS Group (471A) IPO: The Investment Case
  • SBI Shinsei Bank Pre-IPO – Peer Comparison
  • Pre-IPO Guangzhou Xiao Noodles Catering Management (PHIP Updates) – Some Points Worth the Attention


UltraGreen.ai IPO: High Growth and High Margins, Market Leader

By Hong Jie Seow

  • UltraGreen.AI (2594794D SP) is looking to raise US$400m in its upcoming Singapore IPO.
  • UltraGreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
  • We have looked at the company’s past performance in our previous note. In this note, we talk about valuations.

Klook Travel Technology (KLK): Peeking at the IPO Prospectus of a Hong Kong Based Travel Platform

By IPO Boutique

  • Klook leads APAC’s fast-growing travel-experiences market with mobile-first, AI-driven personalization and deep merchant integration across 310,000 offerings in 4,200 destinations.
  • Rapid GTV and profit-margin improvement highlight growing scale, strengthened monetization, and rising APAC demand in an under-digitized, fragmented global experiences sector.
  • Despite strong positioning, IPO prospects face scrutiny given sector volatility and recent peer underperformance, warranting cautious investor evaluation ahead of 2025 pricing.

Chagee Holdings (CHA) Six-Month Summary: Stark Warning on Volatility, China-Based IPO Risk

By IPO Boutique

  • Chagee’s IPO surged early but collapsed, falling nearly 70% from its debut high amid intense market and China-based issuer volatility.
  • Weak U.S. sponsorship and a sales miss triggered sustained selling pressure, pushing CHA far below its $28 issue price.
  • The deal highlights 2025’s unforgiving IPO environment, where consumer and China-linked listings face sharp downside risk when momentum fades.

Hornbeck Offshore Services, Inc. (HOS): Peeking at the IPO Prospectus of Marine Services Company

By IPO Boutique

  • Hornbeck operates one of the world’s largest high-spec offshore fleets, serving diversified markets including oilfield services, military support, and emerging offshore wind.
  • Strong revenue growth and consistent profitability reflect resilient demand across deepwater energy, specialty services, and expanding non-oilfield markets.
  • IPO prospects hinge on market timing and valuation, as energy-related offerings have produced mixed results in 2025.

NS Group (471A) IPO: The Investment Case

By Arun George

  • NS Group (471A JP) is a Japanese property rent guarantee company. It is seeking to raise up to US$255 million. Pricing is on 1 December and listing is on 16 December.   
  • The controlling shareholder is Bain Capital, which owns 51.0% of voting rights. The offering is a pure secondary sale by Bain.   
  • The investment case rests on its unique market positioning, accelerating growth, sector-leading profitability, cash generation, and low leverage. 

SBI Shinsei Bank Pre-IPO – Peer Comparison

By Sumeet Singh

  • SBI Shinsei Bank (8303 JP), a Japanese financial institution, aims to raise around US$2bn in its Japan listing.
  • SBI Shinsei Bank (SBISB) is a Japanese financial institution providing a range of financial products and services to both individual and institutional customers.
  • We have looked at past performance in our earlier notes. In this note, we undertake a peer comparison

Pre-IPO Guangzhou Xiao Noodles Catering Management (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Xiao Noodles’ advantage doesn’t come from a single product, but from a set of replicable systematic capabilities.However, investors are concerned growth is driven by capital rather than endogenous healthy growth.
  • Valuation would be lower than those mature brands that have proven profitability in the short term, but would be higher than the companies that are still exploring profit paths.
  • Comfortable valuation could be P/E of 15-20x, which indicates arbitrage space. But in long term, business model will be difficult to sustain if there’s no breakthrough in profit margin performance.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: ReNew Energy Global , Capacit’e Infraprojects, Khazanchi Jewellers, Narayana Hrudayalaya Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Lucror Analytics – Morning Views Asia
  • The Beat Ideas- Capacite Infraprojects: Optimizing the Growth Trajectory
  • Khazanchi Jewellers: Scaling Wholesale Strength and Building Retail for the Future
  • Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion


Lucror Analytics – Morning Views Asia

By Trung Nguyen

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: ReNew Energy, China Jinmao
  • UST yields fell on Friday, led by the front end, after New York Fed President John Williams said he saw room for another rate cut in the near term, amid a softening labour market.
  • The yield on the 2Y UST declined 6 bps to 3.53%, while that on the 10Y UST dropped 5 bps to 4.09%. Equities recovered on Friday, but remained down for the week. The S&P 500 and Nasdaq rose 1.0% and 0.9% to 6,603 and 22,273, respectively.
  •  

The Beat Ideas- Capacite Infraprojects: Optimizing the Growth Trajectory

By Sudarshan Bhandari

  • Capacite Infraprojects saw its highest-ever Q2 performance with 24% YoY income growth. It achieved nearly its full-year order inflow target of Rs. 3,500 crores in H1 FY26, signaling strong execution. 
  • The Rs. 11,991 crores order book provides robust 4.5x revenue visibility, and a shift towards the upper end of the 16.5%-17.5% EBITDA margin guidance suggests improving operational efficiency and profitability.
  • CIL is set for sustained, high-double-digit growth with major H2 FY26 project ramp-ups and a Rs. 4,000 crores FY28 revenue target, necessitating a focus on execution and working capital strategies.

Khazanchi Jewellers: Scaling Wholesale Strength and Building Retail for the Future

By Sudarshan Bhandari

  • Khazanchi Jewellers posts a strong Q2FY26 with 46% revenue growth, 119% PAT surge, and a major 10,000 sq. ft. Chennai flagship store set to launch in Jan 2026.
  • High-Margin retail and diamond segments are accelerating, supported by a stable B2B engine with 90% repeat orders, positioning the company for structural margin expansion and stronger long-term earnings visibility.
  • Khazanchi enters a high-growth phase, with premiumisation, retail expansion, and strong execution driving sustainable profitability and transforming it from a wholesale-led player into a high-margin retail-focused jewellery brand.

Narayana Hrudayalaya: A Quarter of Record Performance and Strategic Expansion

By Sudarshan Bhandari

  • NARH delivered its best-ever quarter in Q2FY26, with 20.3% YoY revenue growth, 30.3% YoY EBITDA growth and margin expansion across India and Cayman.
  • Margins improved even with limited capacity, showing stronger earnings quality. Cayman maintains over 40% margins, and India is preparing for a major INR 3,000 crore expansion phase.
  • With India easing capacity limits, Cayman scaling, and the UK Practice Plus acquisition expanding global reach, NARH is evolving into a stronger multi-country healthcare platform with long-term growth potential.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars